Patents
Patents for C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723)
10/2008
10/30/2008US20080267983 Mimetic peptide for use in treatment and prevention of stroke, cardiovascular, neurodegenerative, inflammatory and vision defects
10/30/2008US20080267867 Imidazole, pyridine derivative silver complexes; nanofiber with radioactive transition metal, lanthanide, actinide; radiopharmaceutical peptide, polyamine, imaging and tumor treatment
10/30/2008CA2684575A1 Modified plant defensin
10/28/2008US7442788 Nucleosides; peptide nucleic acids; orientation of sugar governs positioning of antisense molecule
10/28/2008US7442764 Reversible modification of amine-containing compounds
10/23/2008WO2007131218A3 Compositions and methods for modulating the immune system
10/23/2008WO2006121926A8 Neural regeneration peptides and methods for their use
10/23/2008WO2005065382A8 Polypeptides and immunogenic conjugates capable of inducing antibodies against pathogens, and uses thereof
10/23/2008US20080262199 Kit comprising inhibitory peptide for use in reducing side effects of drug cessation
10/23/2008US20080261277 Circularly permuted RNA molecule carrying a stabilized biologically active RNA; antisense RNA; gene expression inhbition; ribozyme
10/23/2008US20080260789 Expressed in venom glands of spiders; polynucleotides; transgenic plant or insect
10/23/2008US20080260769 Protein comprising antigenic, oligomerization, transmembrane and adhesin domains; improving membrane surface expression of heterologous protein
10/23/2008US20080260763 High Throughput Proteomics
10/23/2008US20080260691 Conjugated with amino acids, peptides, glycopeptides; bioavailability
10/22/2008EP1017725B1 Method of affinity cross-linking biologically active, immunogenic peptides to antibodies
10/22/2008CN101289494A Cyclic peptides with vasodilator action, preparation and uses thereof
10/22/2008CN101289394A Process for abstracting chlorogenic acid and separating protein and small peptide form sunflower meal
10/21/2008US7439333 Vascular endothelial growth factor 2
10/21/2008US7438917 Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes
10/16/2008WO2008124139A1 High pressure inclusion body solubilization in the presence of a protease
10/16/2008US20080255026 Glycopegylated Factor Ix
10/16/2008US20080255025 Protease inhibition
10/16/2008US20080253992 Using hydrophobic interaction chromatography to recover therapeutic fusion protein for use in treatment of injuries associated with ischemia, trauma, inflammation and contact with toxic substances
10/14/2008US7435791 Preparing amino acid sequences in organic solvent or mixture of organic solvents; in vitro translation; mimetics
10/14/2008US7435718 CXCR4 antagonist treatment of hematopoietic cells
10/14/2008US7435716 Compounds pharmaceutical compositions and methods for treatment of bacteremia and/or septicemia
10/14/2008CA2457584C Enhancing solubility of iron amino acid chelates and iron proteinates
10/14/2008CA2255865C Synthesis of soluble beta-sheet forming peptides
10/09/2008WO2008054597A3 Tyrosine phosphorylation sites
10/09/2008US20080248995 Contact candidate compound with transfected expression vector containing heterologous gene linked to PPAR promoter and expression vector encoding FOXO1 protein; compare level of expression with absence of candidate to identify promoter
10/09/2008US20080248569 Self-assembling peptide amphiphiles for tissue engineering
10/09/2008US20080248522 High-pressure inclusion body solubilization and protease clipping of recombinant fusion proteins
10/09/2008US20080248462 Using peptidase as evaluative tool in identifying modulators for prevention and treatment of cardiovascular, endocrinological, metabolic, cell proliferative, inflammatory, gastrointestinal, blood, respiratory, nervous system, urogenital and reproduction disorders
10/09/2008US20080247999 Cyclin dependent kinase-4 (CDK-4) peptides for use in treatment of cell proliferative disorders; antitumor agents
10/09/2008US20080247946 Bombesin capable of complexing with metal ions, radionuclides, or optical labels; radiotherapy
10/08/2008CN101280305A Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
10/07/2008US7432240 Fumaric acid amides
10/07/2008US7432239 Polyoxyalkylene compound and method for making
10/07/2008US7432061 Assays for measuring matrix metalloproteinase activities
10/02/2008US20080242843 Function of a haptoglobin-haemoglobin receptor and the uses thereof
10/02/2008US20080242838 Multifunctional labels in proteomics; lysine specific and increase overall sequence coverage obtained in polypeptide mapping by increasing ionization efficiencies
10/02/2008US20080242837 Peptide compositions
10/02/2008US20080242834 Recombinant protein comprising hydroxyproline glycosylated residues; antagonist/agonist biosynthesis
10/02/2008US20080242590 New Method 706
10/02/2008US20080242587 Including nucleotide sequence encoding Tie2 and vascular endothelial growth factor receptor (VEGF) components; edema and tumor growth prevention
10/02/2008US20080241878 Method For Enzmatic Cross-Linking Of A Protein, Cross-Linked Protein Thus Obatained And Use Thereof
10/02/2008US20080241855 GAG protein immunoglobulin fusion for use in detection of hepatitis C virus and human immunodeficiency viral infection
10/02/2008US20080241175 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction
10/02/2008US20080241168 Transmembrane protein amigo and uses thereof
10/02/2008US20080241144 Prohibitin as Target for Cancer Therapy
10/02/2008US20080241104 Espfu nucleic acids and proteins and uses thereof
10/02/2008US20080241102 Nucleophile/biodrug cascades
10/02/2008CA2681567A1 Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
10/01/2008EP1975234A2 Therapeutic and diagnotics agents capable of modulating cellular responsiveness to cytokines
09/2008
09/30/2008CA2285573C A method for stimulating red blood cell production
09/25/2008WO2006069246A3 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
09/25/2008US20080234176 Modified peptides and their uses
09/25/2008US20080233139 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells
09/24/2008EP1521771B1 STREPTOCOCCUS PNEUMONIAE PBP2x MINI-PROTEIN AND USES THEREOF.
09/23/2008US7427663 Cardio myopeptidin, the production and the use thereof
09/23/2008US7427656 Peptide tags for the expression and purification of bioactive peptides
09/18/2008US20080227686 Novel Peptides that Promote Lipid Efflux
09/18/2008US20080227684 Small Molecule Inhibitors of PDZ Interactions
09/18/2008US20080227169 Immobilization
09/18/2008US20080227125 Using cardiovascular disorder plasma polypeptides (CPPs) as evaluative tools in detection coronary artery disease
09/18/2008US20080226666 Immunogenic polypeptide for protecting pigs against viral infection or postweaning multisystemic wasting syndrome
09/18/2008US20080226644 Nucleotide sequences coding breast cancer protein (BCMP 101) for use in developing vaccines and immunoglobulin which target and destroy tumor tissues; antitumor agents
09/18/2008US20080226639 Heparin Binding Peptide
09/18/2008US20080226554 Polynucleotides encoding markers
09/17/2008CN101267829A Thrombospondin-1 derived peptides and treatment methods
09/17/2008CN100418981C Gene differentially expressed in breast and bladder cancer and encoded polypeptides
09/16/2008US7425608 Combinatorial library of different sequence peptide members synthesized on solid phase, where each constituent library member includes peptide sequence of three or more amino acid residues bound to solid phase characterized by sequence of two or more amino acid residues forming a metal ion-binding domain
09/16/2008US7425606 Identifying cryptic epitopes comprising amino acid sequences of tumor antigen for diagnosis and treatment of viral and cancer disorder; viricides; antitumor agents
09/16/2008US7425333 Hypoallergenic allergy vaccines based on the timothy grass pollen allergen Phl p 7
09/15/2008CA2624573A1 Method of obtaining vegetable proteins and/or peptides, proteins produced according to said method and/or peptides and use thereof
09/11/2008US20080221012 Polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; efficient, less dangerous production method; botulinum neurotoxins targeted to specific cell types
09/11/2008US20080221011 CR2-FH C-reactive protein, factor H fusion protein; inhibiting complement activation of the alternative pathway
09/11/2008US20080219998 Anticoagulant for use in treatment and prevention of thrombosis or thrombin-dependent vaso-occlusive disease; selective reduction of intravascular thromboplastin antecedent activity
09/11/2008US20080219990 Compositions and methods for the therapy and diagnosis of breast cancer
09/11/2008US20080219970 Identification and molecular characterisation of proteins, expressed in the ixodes ricinus salivary glands
09/09/2008US7423021 Peptidic thrombin inhibitors
09/09/2008CA2622649A1 Primer, primer set, and nucleic acid amplification method and mutation detection method using the same
09/09/2008CA2135833C Antigen carbohydrate compounds and their use in immunotherapy
09/04/2008WO2007044396A3 Fibronectin polypeptides and methods of use
09/04/2008US20080214782 Amino acid sequence phosphorylation site motif; structural variance and disease diagnosis
09/04/2008US20080214781 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders
09/04/2008US20080214514 Derivatives in which cholesterol or a cholesterol moiety is attached via ester, amide, or ether bonds to one of a variety of "linkers," e.g., chemical groups including alkyl chains and aromatic groups, which are then connected to fullerene moiety; steroid moiety confers solubility in biofluids; imaging
09/04/2008US20080214494 Method of drug delivery by carbon nanotube-chitosan nanocomplexes
09/04/2008US20080214468 Administering a peptide, identified through a phage display library; osteogenesis, cell adhesion/angiogenesis, inhibiting cancer cell metastasis
09/04/2008US20080214437 RNA interference; gene therapy; inhalers
09/04/2008US20080214406 Look-Through Mutagenesis For Developing Altered Polypeptides With Enhanced Properties
09/04/2008US20080213917 Hydroxy-isophthalamide moieties; antibodies; high stability, luminescence; kits
09/04/2008US20080213840 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
09/04/2008US20080213824 Fluorescence in situ hybridization staining employing an aqueous acetonitrile/dimethylsulfoxide mixture in fluorophore coupling reaction
09/04/2008US20080213784 Screening methods and sequences relating thereto
09/04/2008US20080213377 Delivery of Nanoparticles and/or Agents to Cells
09/04/2008US20080213285 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof
09/04/2008US20080213166 Novel Gene Targets and Ligands that Bind Thereto for Treatment and Diagnosis of Colon Carcinomas
09/03/2008EP1963356A2 Accelerated angiogenesis-inducing protein, compositions inducing accelerated angiogenesis and uses thereof
09/03/2008CN101258160A Natural killer cell compositions and method for production of the same
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 48